SEC Comment Letter 0000000000-23-007734 to Polomar Health Services, Inc. (PMHS)
Polomar Health Services, Inc.
Date: July 20, 2023 · CIK: 0001265521 · Accession: 0000000000-23-007734
AI Filing Summary & Sentiment
File numbers found in text: 000-56555
Show Raw Text
United States securities and exchange commission logo
July 20, 2023
Rasmus Refer
Chief Executive Officer
Trustfeed Corp.
140 Broadway, 46th Floor
New York, NY 10005
Re:Trustfeed Corp.
Amendment No. 1 to Registration Statement on Form 10-12G
Filed July 6, 2023
File No. 000-56555
Dear Rasmus Refer:
We have reviewed your filing and have the following comments. In some of our
comments, we may ask you to provide us with information so we may better understand your
disclosure.
Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
After reviewing your response to these comments, we may have additional
comments. Unless we note otherwise, our references to prior comments are to comments in our
June 27, 2023 letter.
Amendment No. 1 to Registration Statement on Form 10-12G filed on July 6, 2023
Products and Services, page 3
1.We note your response to prior comment 3 and also note your revised disclosure on pages
F-7 and F-15, indicating that the company generates revenue from customized data
packages, which is a Leads Ordering system for the purpose of generating lists of sales
leads. Please revise to ensure that the information in your "Products and Services" section
on page 3 is consistent with your disclosures on page F-7 and F-15, and your "Revenue
Models" section on page 5.
FirstName LastNameRasmus Refer
Comapany NameTrustfeed Corp.
July 20, 2023 Page 2
FirstName LastName
Rasmus Refer
Trustfeed Corp.
July 20, 2023
Page 2
Business
Competition, page 6
2.We note your response to prior comment 5, including your statement that your offer
similar services to several leading companies "but with a much larger platform." To the
extent you continue to include this disclosure, please provide support for this and other
similar statements and ensure you provide balanced disclosure. For example, to the extent
that you compare the size of your company platform to the platforms of leading
competitors, please support your claims by providing numerical information for each
competitor along with the source of the information relied upon. Additionally, to balance
this disclosure, please ensure you discuss that these other companies have much higher
revenue and user counts, among other metrics, than you.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
You may contact Claire DeLabar, Senior Staff Accountant, at 202-551-3349 or Robert
Littlepage, Accounting Branch Chief, at 202-551-3361 if you have questions regarding
comments on the financial statements and related matters. Please contact Mariam Mansaray,
Staff Attorney, at 202-551-6356 or Mitchell Austin, Staff Attorney, at 202-551-3574 with any
other questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Scott Doney